Loading…
Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin‐activatable fibrinolysis inhibitor activation in whole blood model thrombi
Saved in:
Published in: | Journal of thrombosis and haemostasis 2013-01, Vol.11 (1), p.190-192 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4542-8a7b1867f7bb2a2b156f52496e7bb17aebf27dfb5b7f620779e22a665c5121f63 |
---|---|
cites | cdi_FETCH-LOGICAL-c4542-8a7b1867f7bb2a2b156f52496e7bb17aebf27dfb5b7f620779e22a665c5121f63 |
container_end_page | 192 |
container_issue | 1 |
container_start_page | 190 |
container_title | Journal of thrombosis and haemostasis |
container_volume | 11 |
creator | VERCAUTEREN, E. MUTCH, N. J. DECLERCK, P. J. GILS, A. |
description | |
doi_str_mv | 10.1111/jth.12062 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1282513997</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2875821111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4542-8a7b1867f7bb2a2b156f52496e7bb17aebf27dfb5b7f620779e22a665c5121f63</originalsourceid><addsrcrecordid>eNp1kcFqHCEYxyUkdNNND3mBMpBLc9isOqvOHENIk5aF9LA5i84o4-LoVp0ke-sjFHLL4_VJajq7pQQqiJ8fv--n8AfgFMELlNd8nboLhCHFB-AYkbKasaqkh_u6LssJeB_jGkJUEwzfgQku0QLCujoGL9-siL1xhXBtkTqVd_C9NO7Xj-ex9L1vB5uJxvcbq54K6VOXLy4FI4eUJ_w_Qz9Fk8yDSEJaVWgjg3HebqOJhXGdkSb5UOwQ411uFo-dz6i03rdFfkrZve0EHGlho_qwO6fg_vP16up2try7-XJ1uZw1C7LAs0owiSrKNJMSCywRoZrgRU1VbiAmlNSYtVoSyTTFkLFaYSwoJQ1BGGlaTsGn0bsJ_vugYuK9iY2yVjjlh8gRrjBBZV2zjJ69Qdd-CC7_7pVCmWCZnILzkWqCjzEozTfB9CJsOYL8NTCeA-N_Asvsx51xkL1q_5L7hDIwH4FHY9X2_yb-dXU7Kn8D_v2lPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1281973751</pqid></control><display><type>article</type><title>Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin‐activatable fibrinolysis inhibitor activation in whole blood model thrombi</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>VERCAUTEREN, E. ; MUTCH, N. J. ; DECLERCK, P. J. ; GILS, A.</creator><creatorcontrib>VERCAUTEREN, E. ; MUTCH, N. J. ; DECLERCK, P. J. ; GILS, A.</creatorcontrib><identifier>ISSN: 1538-7933</identifier><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1111/jth.12062</identifier><identifier>PMID: 23140098</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Antibodies, Monoclonal - pharmacology ; Blood Platelets - drug effects ; Blood Platelets - metabolism ; Carboxypeptidase B2 - antagonists & inhibitors ; Carboxypeptidase B2 - blood ; Enzyme Activation ; Fibrinolysin - metabolism ; Fibrinolysis - drug effects ; Fibrinolytic Agents - pharmacology ; Humans ; Thrombin - metabolism ; Thrombomodulin - metabolism ; Thrombosis - blood ; Time Factors</subject><ispartof>Journal of thrombosis and haemostasis, 2013-01, Vol.11 (1), p.190-192</ispartof><rights>2012 International Society on Thrombosis and Haemostasis</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4542-8a7b1867f7bb2a2b156f52496e7bb17aebf27dfb5b7f620779e22a665c5121f63</citedby><cites>FETCH-LOGICAL-c4542-8a7b1867f7bb2a2b156f52496e7bb17aebf27dfb5b7f620779e22a665c5121f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23140098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VERCAUTEREN, E.</creatorcontrib><creatorcontrib>MUTCH, N. J.</creatorcontrib><creatorcontrib>DECLERCK, P. J.</creatorcontrib><creatorcontrib>GILS, A.</creatorcontrib><title>Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin‐activatable fibrinolysis inhibitor activation in whole blood model thrombi</title><title>Journal of thrombosis and haemostasis</title><addtitle>J Thromb Haemost</addtitle><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Blood Platelets - drug effects</subject><subject>Blood Platelets - metabolism</subject><subject>Carboxypeptidase B2 - antagonists & inhibitors</subject><subject>Carboxypeptidase B2 - blood</subject><subject>Enzyme Activation</subject><subject>Fibrinolysin - metabolism</subject><subject>Fibrinolysis - drug effects</subject><subject>Fibrinolytic Agents - pharmacology</subject><subject>Humans</subject><subject>Thrombin - metabolism</subject><subject>Thrombomodulin - metabolism</subject><subject>Thrombosis - blood</subject><subject>Time Factors</subject><issn>1538-7933</issn><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp1kcFqHCEYxyUkdNNND3mBMpBLc9isOqvOHENIk5aF9LA5i84o4-LoVp0ke-sjFHLL4_VJajq7pQQqiJ8fv--n8AfgFMELlNd8nboLhCHFB-AYkbKasaqkh_u6LssJeB_jGkJUEwzfgQku0QLCujoGL9-siL1xhXBtkTqVd_C9NO7Xj-ex9L1vB5uJxvcbq54K6VOXLy4FI4eUJ_w_Qz9Fk8yDSEJaVWgjg3HebqOJhXGdkSb5UOwQ411uFo-dz6i03rdFfkrZve0EHGlho_qwO6fg_vP16up2try7-XJ1uZw1C7LAs0owiSrKNJMSCywRoZrgRU1VbiAmlNSYtVoSyTTFkLFaYSwoJQ1BGGlaTsGn0bsJ_vugYuK9iY2yVjjlh8gRrjBBZV2zjJ69Qdd-CC7_7pVCmWCZnILzkWqCjzEozTfB9CJsOYL8NTCeA-N_Asvsx51xkL1q_5L7hDIwH4FHY9X2_yb-dXU7Kn8D_v2lPA</recordid><startdate>201301</startdate><enddate>201301</enddate><creator>VERCAUTEREN, E.</creator><creator>MUTCH, N. J.</creator><creator>DECLERCK, P. J.</creator><creator>GILS, A.</creator><general>Blackwell Publishing Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201301</creationdate><title>Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin‐activatable fibrinolysis inhibitor activation in whole blood model thrombi</title><author>VERCAUTEREN, E. ; MUTCH, N. J. ; DECLERCK, P. J. ; GILS, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4542-8a7b1867f7bb2a2b156f52496e7bb17aebf27dfb5b7f620779e22a665c5121f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Blood Platelets - drug effects</topic><topic>Blood Platelets - metabolism</topic><topic>Carboxypeptidase B2 - antagonists & inhibitors</topic><topic>Carboxypeptidase B2 - blood</topic><topic>Enzyme Activation</topic><topic>Fibrinolysin - metabolism</topic><topic>Fibrinolysis - drug effects</topic><topic>Fibrinolytic Agents - pharmacology</topic><topic>Humans</topic><topic>Thrombin - metabolism</topic><topic>Thrombomodulin - metabolism</topic><topic>Thrombosis - blood</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VERCAUTEREN, E.</creatorcontrib><creatorcontrib>MUTCH, N. J.</creatorcontrib><creatorcontrib>DECLERCK, P. J.</creatorcontrib><creatorcontrib>GILS, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VERCAUTEREN, E.</au><au>MUTCH, N. J.</au><au>DECLERCK, P. J.</au><au>GILS, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin‐activatable fibrinolysis inhibitor activation in whole blood model thrombi</atitle><jtitle>Journal of thrombosis and haemostasis</jtitle><addtitle>J Thromb Haemost</addtitle><date>2013-01</date><risdate>2013</risdate><volume>11</volume><issue>1</issue><spage>190</spage><epage>192</epage><pages>190-192</pages><issn>1538-7933</issn><issn>1538-7836</issn><eissn>1538-7836</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>23140098</pmid><doi>10.1111/jth.12062</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1538-7933 |
ispartof | Journal of thrombosis and haemostasis, 2013-01, Vol.11 (1), p.190-192 |
issn | 1538-7933 1538-7836 1538-7836 |
language | eng |
recordid | cdi_proquest_miscellaneous_1282513997 |
source | Free E-Journal (出版社公開部分のみ) |
subjects | Antibodies, Monoclonal - pharmacology Blood Platelets - drug effects Blood Platelets - metabolism Carboxypeptidase B2 - antagonists & inhibitors Carboxypeptidase B2 - blood Enzyme Activation Fibrinolysin - metabolism Fibrinolysis - drug effects Fibrinolytic Agents - pharmacology Humans Thrombin - metabolism Thrombomodulin - metabolism Thrombosis - blood Time Factors |
title | Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin‐activatable fibrinolysis inhibitor activation in whole blood model thrombi |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A51%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasmin%20and%20the%20thrombin%E2%80%93thrombomodulin%20complex%20both%20contribute%20to%20thrombin%E2%80%90activatable%20fibrinolysis%20inhibitor%20activation%20in%20whole%20blood%20model%20thrombi&rft.jtitle=Journal%20of%20thrombosis%20and%20haemostasis&rft.au=VERCAUTEREN,%20E.&rft.date=2013-01&rft.volume=11&rft.issue=1&rft.spage=190&rft.epage=192&rft.pages=190-192&rft.issn=1538-7933&rft.eissn=1538-7836&rft_id=info:doi/10.1111/jth.12062&rft_dat=%3Cproquest_cross%3E2875821111%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4542-8a7b1867f7bb2a2b156f52496e7bb17aebf27dfb5b7f620779e22a665c5121f63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1281973751&rft_id=info:pmid/23140098&rfr_iscdi=true |